HAMP and placenta praevia: Table 1 provides an overview of the study participants’ baseline maternal and pregnancy-related characteristics as well as pregnancy outcomes, according to cord blood hepcidin levels of the nonhemolyzed samples. With regard to pregnancy complications, the following complications were reported in this cohort: preeclampsia (N = 3), gestational diabetes (N = 3), placenta previa (N = 1), hyperemesis gravidarum (N = 1), polyhydramnios (N = 1) and cardiac complications (N = 1).